ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00447915
Recruitment Status : Completed
First Posted : March 15, 2007
Last Update Posted : August 2, 2012
Sponsor:
Information provided by (Responsible Party):
Chugai Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : December 2011